ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0006935,chemotaxis,20/163,239/10799,4.63320963020683e-10,6.319697935602117e-7,4.962411367089948e-7,CCR2/PDGFRB/STAP1/CCR1/PLAUR/CXCL8/NRP1/EGR3/KIT/CCR6/HSPB1/NR4A1/DAPK2/CCL3L1/ACKR2/FCER1G/SLIT1/PLAU/PDGFA/VAV3,20
GO:0042330,taxis,20/163,239/10799,4.63320963020683e-10,6.319697935602117e-7,4.962411367089948e-7,CCR2/PDGFRB/STAP1/CCR1/PLAUR/CXCL8/NRP1/EGR3/KIT/CCR6/HSPB1/NR4A1/DAPK2/CCL3L1/ACKR2/FCER1G/SLIT1/PLAU/PDGFA/VAV3,20
GO:0060326,cell chemotaxis,16/163,166/10799,3.702772561011427e-9,3.3670545154797245e-6,2.643909530406405e-6,CCR2/PDGFRB/STAP1/CCR1/CXCL8/NRP1/EGR3/KIT/CCR6/HSPB1/NR4A1/DAPK2/CCL3L1/ACKR2/FCER1G/VAV3,16
GO:0002252,immune effector process,23/163,404/10799,3.747385151027283e-8,2.555716673000607e-5,2.0068233637738213e-5,CCR2/STAP1/ITGAM/CD300A/KLRD1/KIT/GZMB/CCR6/CD70/ZNF683/SPON2/IL13/EOMES/FCER1G/KLRC2/IRF8/RSAD2/AICDA/ADORA2B/IL21/RORC/VAV3/SRC,23
GO:0002443,leukocyte mediated immunity,17/163,262/10799,4.196913840868848e-7,2.2898361915780436e-4,1.7980462455090748e-4,CCR2/STAP1/ITGAM/CD300A/KLRD1/KIT/GZMB/CCR6/CD70/SPON2/IL13/FCER1G/KLRC2/RSAD2/AICDA/ADORA2B/IL21,17
GO:0002366,leukocyte activation involved in immune response,15/163,213/10799,7.430593267503832e-7,3.29989770829557e-4,2.5911760442898154e-4,CCR2/ITGAM/CD300A/KIT/CCR6/ZNF683/IL13/EOMES/FCER1G/KLRC2/IRF8/AICDA/ADORA2B/IL21/RORC,15
GO:0002263,cell activation involved in immune response,15/163,216/10799,8.877439003144475e-7,3.29989770829557e-4,2.5911760442898154e-4,CCR2/ITGAM/CD300A/KIT/CCR6/ZNF683/IL13/EOMES/FCER1G/KLRC2/IRF8/AICDA/ADORA2B/IL21/RORC,15
GO:0042063,gliogenesis,14/163,190/10799,1.0293204903059477e-6,3.29989770829557e-4,2.5911760442898154e-4,CDK5R1/MAL/CCR2/STAP1/EGR2/CDKN2B/SOX4/ETV5/BMERB1/GPR157/EOMES/CDH2/MYRF/NAB2,14
GO:0032103,positive regulation of response to external stimulus,20/163,380/10799,1.0886759301561632e-6,3.29989770829557e-4,2.5911760442898154e-4,CCR2/PDGFRB/STAP1/CCR1/CD300A/CXCL8/KLRD1/NRP1/CCR6/HSPB1/SCARF1/DAPK2/AIM2/KLRC2/PLAU/RSAD2/ADORA2B/IL21/SRC/PIK3AP1,20
GO:0007186,G protein-coupled receptor signaling pathway,18/163,322/10799,1.6645455483308328e-6,4.540880255846512e-4,3.565631779845521e-4,CDK5R1/CCR2/PDE4A/PDGFRB/CCR1/CXCL8/CCR6/ADM/GABBR1/GPR157/CCL3L1/ACKR2/BCAR3/SORT1/AGRN/ADORA2B/APLN/SRC,18
GO:0007599,hemostasis,11/163,124/10799,2.5701220958811065e-6,6.373902797785144e-4,5.00497460776847e-4,PLAUR/HSPB1/F5/TSPAN18/FCER1G/PLAU/F12/PDGFA/GP5/VAV3/SRC,11
GO:0035914,skeletal muscle cell differentiation,7/163,43/10799,3.2016752282334043e-6,6.928167101094497e-4,5.440199124373864e-4,EGR1/FOS/EGR2/ASB2/NR4A1/EOMES/MAFF,7
GO:0050865,regulation of cell activation,21/163,445/10799,3.3015459059467914e-6,6.928167101094497e-4,5.440199124373864e-4,CCR2/STAP1/ITGAM/CD300A/SOX4/KLRD1/EGR3/IGF2/CD70/ZNF683/IL13/FCER1G/TNFSF9/KLRC2/DLG5/ADORA2B/IL21/PDGFA/GP5/VAV3/SRC,21
GO:0002444,myeloid leukocyte mediated immunity,8/163,62/10799,3.8385854102622424e-6,7.479757856568141e-4,5.873324293145612e-4,CCR2/STAP1/ITGAM/CD300A/KIT/SPON2/IL13/ADORA2B,8
GO:0045055,regulated exocytosis,11/163,132/10799,4.741469571162426e-6,8.6231526600874e-4,6.771151282326693e-4,CCR2/ITGAM/CD300A/KIT/OTOF/IL13/TSPAN18/KLRC2/ADORA2B/CPLX1/PFN2,11
GO:0050878,regulation of body fluid levels,13/163,189/10799,5.446793686910617e-6,9.286783236182602e-4,7.292253390041517e-4,PLAUR/HSPB1/ADM/F5/TSPAN18/FCER1G/PLAU/F12/APLN/PDGFA/GP5/VAV3/SRC,13
GO:0050900,leukocyte migration,14/163,226/10799,7.91714953597865e-6,0.0011262077686581952,8.843312275117407e-4,CCR2/STAP1/CCR1/CD300A/ASB2/SMPD3/CXCL8/KIT/CCR6/DAPK2/CCL3L1/FCER1G/VAV3/SRC,14
GO:0061061,muscle structure development,19/163,396/10799,7.941935255271248e-6,0.0011262077686581952,8.843312275117407e-4,EGR1/FOS/PDGFRB/EGR2/ASB2/SOX4/EGR3/KIT/IGF2/ETV1/ADM/NR4A1/EOMES/CDH2/MAFF/SORT1/TNNT3/DOCK5/PDLIM1,19
GO:0035924,cellular response to vascular endothelial growth factor stimulus,6/163,33/10799,8.523430325287375e-6,0.0011262077686581952,8.843312275117407e-4,PDGFRB/NRP1/EGR3/HSPB1/NR4A1/PTP4A3,6
GO:0043300,regulation of leukocyte degranulation,6/163,33/10799,8.523430325287375e-6,0.0011262077686581952,8.843312275117407e-4,CCR2/ITGAM/CD300A/IL13/KLRC2/ADORA2B,6
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,18/163,363/10799,8.929475147062665e-6,0.0011262077686581952,8.843312275117407e-4,CDK5R1/PDGFRB/STAP1/PLAUR/SMPD3/SHC4/NRP1/KIT/HSPB1/IGF2/SPRY4/FASLG/BCAR3/SORT1/PTP4A3/APLN/PDGFA/SRC,18
GO:0043299,leukocyte degranulation,7/163,50/10799,9.082320714985445e-6,0.0011262077686581952,8.843312275117407e-4,CCR2/ITGAM/CD300A/KIT/IL13/KLRC2/ADORA2B,7
GO:0099536,synaptic signaling,18/163,369/10799,1.1172537253647983e-5,0.0013251600707805085,0.001040554384950739,CDK5R1/CCR2/EGR2/NPTX1/PTPRN2/EGR3/KIT/PDE9A/OTOF/NR4A1/GABBR1/GAD1/CDH2/MPZ/AGRN/ADORA2B/CPLX1/PFN2,18
GO:0001944,vasculature development,19/163,408/10799,1.2139655897788148e-5,0.0013610904961999532,0.001068768004231712,EGR1/CCR2/PDGFRB/TNFRSF12A/EGR2/SOX4/CXCL8/NRP1/EGR3/KIT/HSPB1/ADM/FASLG/NR4A1/TSPAN18/CDH2/APLN/PDGFA/VAV3,19
GO:0006954,inflammatory response,21/163,485/10799,1.2473336658723911e-5,0.0013610904961999532,0.001068768004231712,CCR2/FOS/STAP1/CCR1/ITGAM/CXCL8/KIT/CCR6/ADM/NR4A1/IL13/TSPAN18/CCL3L1/ACKR2/AIM2/CD68/F12/ADORA2B/IL21/SRC/PIK3AP1,21
GO:0002699,positive regulation of immune effector process,12/163,175/10799,1.30666035117039e-5,0.0013709882453818553,0.001076540005923783,CCR2/STAP1/ITGAM/CD300A/KLRD1/KIT/SPON2/IL13/KLRC2/RSAD2/ADORA2B/IL21,12
GO:0007596,blood coagulation,10/163,121/10799,1.397522135771706e-5,0.0014120149579204496,0.0011087553786726793,PLAUR/HSPB1/F5/FCER1G/PLAU/F12/PDGFA/GP5/VAV3/SRC,10
GO:0050817,coagulation,10/163,122/10799,1.5027586312999835e-5,0.0014641162664951269,0.0011496668476298746,PLAUR/HSPB1/F5/FCER1G/PLAU/F12/PDGFA/GP5/VAV3/SRC,10
GO:0030217,T cell differentiation,14/163,242/10799,1.7218546491070462e-5,0.0015766460996798014,0.001238028558746873,EGR1/CCR2/SOX4/EGR3/KIT/CCR6/ZNF683/EOMES/FCER1G/TNFSF9/JAG2/RSAD2/IL21/RORC,14
GO:0050920,regulation of chemotaxis,10/163,124/10799,1.7338483500877582e-5,0.0015766460996798014,0.001238028558746873,CCR2/PDGFRB/STAP1/CCR1/CXCL8/NRP1/CCR6/HSPB1/DAPK2/SLIT1,10
GO:0097529,myeloid leukocyte migration,10/163,125/10799,1.860428289974429e-5,0.0016323327387244356,0.001281755333888033,CCR2/STAP1/CCR1/CD300A/CXCL8/KIT/DAPK2/CCL3L1/FCER1G/VAV3,10
GO:0001568,blood vessel development,18/163,384/10799,1.9147598108204523e-5,0.0016323327387244356,0.001281755333888033,EGR1/CCR2/PDGFRB/TNFRSF12A/EGR2/SOX4/CXCL8/NRP1/EGR3/HSPB1/ADM/FASLG/NR4A1/TSPAN18/CDH2/APLN/PDGFA/VAV3,18
GO:0002886,regulation of myeloid leukocyte mediated immunity,6/163,38/10799,1.996035327604834e-5,0.001644189642066111,0.001291065720637651,CCR2/STAP1/ITGAM/CD300A/IL13/ADORA2B,6
GO:0030595,leukocyte chemotaxis,10/163,127/10799,2.137585982538821e-5,0.001644189642066111,0.001291065720637651,CCR2/STAP1/CCR1/CXCL8/KIT/CCR6/DAPK2/CCL3L1/FCER1G/VAV3,10
GO:0042110,T cell activation,19/163,425/10799,2.1504999319224995e-5,0.001644189642066111,0.001291065720637651,EGR1/CCR2/CD300A/SOX4/EGR3/KIT/CCR6/IGF2/CD70/ZNF683/EOMES/FCER1G/TNFSF9/DLG5/JAG2/RSAD2/IL21/RORC/SRC,19
GO:0050921,positive regulation of chemotaxis,8/163,78/10799,2.1697517270667156e-5,0.001644189642066111,0.001291065720637651,CCR2/PDGFRB/CCR1/CXCL8/NRP1/CCR6/HSPB1/DAPK2,8
GO:1903131,mononuclear cell differentiation,17/163,354/10799,2.430836032457053e-5,0.0017922488369034703,0.0014073261240540834,EGR1/CCR2/FOS/SOX4/EGR3/KIT/CCR6/ZNF683/EOMES/FCER1G/TNFSF9/IRF8/JAG2/RSAD2/AICDA/IL21/RORC,17
GO:0050867,positive regulation of cell activation,15/163,285/10799,2.6124722849300472e-5,0.0018534942066937643,0.0014554177769029982,CCR2/STAP1/ITGAM/SOX4/EGR3/IGF2/CD70/IL13/TNFSF9/KLRC2/ADORA2B/IL21/GP5/VAV3/SRC,15
GO:0070098,chemokine-mediated signaling pathway,6/163,40/10799,2.7068924637264885e-5,0.0018534942066937643,0.0014554177769029982,CCR2/CCR1/CXCL8/CCR6/CCL3L1/ACKR2,6
GO:0030098,lymphocyte differentiation,16/163,321/10799,2.7177334408999475e-5,0.0018534942066937643,0.0014554177769029982,EGR1/CCR2/SOX4/EGR3/KIT/CCR6/ZNF683/EOMES/FCER1G/TNFSF9/IRF8/JAG2/RSAD2/AICDA/IL21/RORC,16
GO:0006887,exocytosis,13/163,222/10799,3.062087062162546e-5,0.0019867807472952847,0.0015600782608218493,CCR2/CCR1/ITGAM/CD300A/SMPD3/KIT/OTOF/IL13/TSPAN18/KLRC2/ADORA2B/CPLX1/PFN2,13
GO:0002275,myeloid cell activation involved in immune response,7/163,60/10799,3.094509828444298e-5,0.0019867807472952847,0.0015600782608218493,CCR2/ITGAM/CD300A/KIT/IL13/FCER1G/ADORA2B,7
GO:0014910,regulation of smooth muscle cell migration,6/163,41/10799,3.131655870003565e-5,0.0019867807472952847,0.0015600782608218493,PDGFRB/NRP1/PLAU/DOCK5/PDGFA/SRC,6
GO:0002521,leukocyte differentiation,19/163,440/10799,3.468330449280192e-5,0.002150364878553719,0.0016885292976758829,EGR1/CCR2/FOS/CCR1/SOX4/EGR3/KIT/CCR6/ZNF683/EOMES/FCER1G/TNFSF9/IRF8/JAG2/RSAD2/AICDA/IL21/RORC/SRC,19
GO:0048514,blood vessel morphogenesis,16/163,333/10799,4.239959404165194e-5,0.002570357612125033,0.002018319856719572,CCR2/PDGFRB/TNFRSF12A/SOX4/CXCL8/NRP1/EGR3/HSPB1/ADM/FASLG/NR4A1/TSPAN18/CDH2/APLN/PDGFA/VAV3,16
GO:0036230,granulocyte activation,5/163,27/10799,4.546203983570763e-5,0.0026960966233002264,0.0021170538001296347,CCR2/ITGAM/CD300A/CXCL8/FCER1G,5
GO:0002703,regulation of leukocyte mediated immunity,11/163,170/10799,5.165150096467936e-5,0.002974850770312138,0.0023359396965524004,CCR2/STAP1/ITGAM/CD300A/KLRD1/KIT/IL13/KLRC2/RSAD2/ADORA2B/IL21,11
GO:0060627,regulation of vesicle-mediated transport,16/163,339/10799,5.2522624059863095e-5,0.002974850770312138,0.0023359396965524004,CDK5R1/CCR2/STAP1/ITGAM/CD300A/SMPD3/NRP1/IL13/FCER1G/KLRC2/TAMALIN/ADORA2B/CPLX1/APLN/PFN2/SRC,16
GO:0014909,smooth muscle cell migration,6/163,45/10799,5.397154235841194e-5,0.002974850770312138,0.0023359396965524004,PDGFRB/NRP1/PLAU/DOCK5/PDGFA/SRC,6
GO:0009611,response to wounding,15/163,304/10799,5.4992713742167505e-5,0.002974850770312138,0.0023359396965524004,CCR2/CCR1/TNFRSF12A/PLAUR/NRP1/HSPB1/SCARF1/F5/FCER1G/PLAU/F12/PDGFA/GP5/VAV3/SRC,15
GO:0002694,regulation of leukocyte activation,18/163,418/10799,5.8549861951469135e-5,0.002974850770312138,0.0023359396965524004,CCR2/STAP1/ITGAM/CD300A/SOX4/KLRD1/EGR3/IGF2/CD70/ZNF683/IL13/TNFSF9/KLRC2/DLG5/ADORA2B/IL21/VAV3/SRC,18
GO:0030195,negative regulation of blood coagulation,4/163,15/10799,5.9976830046615686e-5,0.002974850770312138,0.0023359396965524004,PLAUR/PLAU/F12/PDGFA,4
GO:0035767,endothelial cell chemotaxis,4/163,15/10799,5.9976830046615686e-5,0.002974850770312138,0.0023359396965524004,NRP1/EGR3/HSPB1/NR4A1,4
GO:0071800,podosome assembly,4/163,15/10799,5.9976830046615686e-5,0.002974850770312138,0.0023359396965524004,FSCN1/ASB2/DOCK5/SRC,4
GO:1900047,negative regulation of hemostasis,4/163,15/10799,5.9976830046615686e-5,0.002974850770312138,0.0023359396965524004,PLAUR/PLAU/F12/PDGFA,4
GO:0017157,regulation of exocytosis,9/163,116/10799,6.256247039234122e-5,0.003047686057684051,0.0023931320911356087,CCR2/ITGAM/CD300A/SMPD3/IL13/KLRC2/ADORA2B/CPLX1/PFN2,9
GO:1990868,response to chemokine,6/163,47/10799,6.940068031218975e-5,0.0032069188708642982,0.0025181663459672974,CCR2/CCR1/CXCL8/CCR6/CCL3L1/ACKR2,6
GO:1990869,cellular response to chemokine,6/163,47/10799,6.940068031218975e-5,0.0032069188708642982,0.0025181663459672974,CCR2/CCR1/CXCL8/CCR6/CCL3L1/ACKR2,6
GO:0002274,myeloid leukocyte activation,10/163,146/10799,7.077888888871471e-5,0.0032069188708642982,0.0025181663459672974,CCR2/STAP1/ITGAM/CD300A/CXCL8/KIT/CD93/IL13/FCER1G/ADORA2B,10
GO:0007268,chemical synaptic transmission,16/163,348/10799,7.170896302152574e-5,0.0032069188708642982,0.0025181663459672974,CCR2/EGR2/NPTX1/PTPRN2/EGR3/KIT/PDE9A/OTOF/NR4A1/GABBR1/GAD1/CDH2/MPZ/ADORA2B/CPLX1/PFN2,16
GO:0098916,anterograde trans-synaptic signaling,16/163,348/10799,7.170896302152574e-5,0.0032069188708642982,0.0025181663459672974,CCR2/EGR2/NPTX1/PTPRN2/EGR3/KIT/PDE9A/OTOF/NR4A1/GABBR1/GAD1/CDH2/MPZ/ADORA2B/CPLX1/PFN2,16
GO:0006909,phagocytosis,10/163,147/10799,7.497171461052555e-5,0.0032902917011447927,0.002583633126960045,CCR2/STAP1/ITGAM/CD300A/CD93/SPON2/FCER1G/IRF8/VAV3/SRC,10
GO:0002696,positive regulation of leukocyte activation,14/163,277/10799,7.598547550297724e-5,0.0032902917011447927,0.002583633126960045,CCR2/STAP1/ITGAM/SOX4/EGR3/IGF2/CD70/IL13/TNFSF9/KLRC2/ADORA2B/IL21/VAV3/SRC,14
GO:0099537,trans-synaptic signaling,16/163,351/10799,7.935161311096783e-5,0.003382362508855004,0.0026559298138292687,CCR2/EGR2/NPTX1/PTPRN2/EGR3/KIT/PDE9A/OTOF/NR4A1/GABBR1/GAD1/CDH2/MPZ/ADORA2B/CPLX1/PFN2,16
GO:0007519,skeletal muscle tissue development,8/163,94/10799,8.399354501933856e-5,0.003525144474042394,0.0027680463824186876,EGR1/FOS/EGR2/ASB2/IGF2/NR4A1/EOMES/MAFF,8
GO:0032496,response to lipopolysaccharide,12/163,213/10799,9.04409605546516e-5,0.0037382263695922664,0.00293536450922992,FOS/STAP1/CXCL8/ADM/SPON2/FASLG/NR4A1/IL13/CD68/IRF8/AICDA/SRC,12
GO:0002697,regulation of immune effector process,13/163,247/10799,9.189200953104625e-5,0.0037415134626969278,0.0029379456307255165,CCR2/STAP1/ITGAM/CD300A/KLRD1/KIT/ZNF683/SPON2/IL13/KLRC2/RSAD2/ADORA2B/IL21,13
GO:0035239,tube morphogenesis,19/163,474/10799,9.429525195144635e-5,0.0037829036371109653,0.002970446404352838,CCR2/PDGFRB/TNFRSF12A/ASB2/SOX4/CXCL8/NRP1/EGR3/HSPB1/ADM/FASLG/NR4A1/TSPAN18/CDH2/DLG5/APLN/PDGFA/VAV3/SRC,19
GO:0006937,regulation of muscle contraction,7/163,72/10799,1.0143894658302061e-4,0.003924363122112179,0.0030815245228809555,KIT/STC1/NR4A1/MYL5/TNNT3/DOCK5/ADORA2B,7
GO:0043302,positive regulation of leukocyte degranulation,4/163,17/10799,1.0213701674118941e-4,0.003924363122112179,0.0030815245228809555,ITGAM/IL13/KLRC2/ADORA2B,4
GO:0050819,negative regulation of coagulation,4/163,17/10799,1.0213701674118941e-4,0.003924363122112179,0.0030815245228809555,PLAUR/PLAU/F12/PDGFA,4
GO:0060538,skeletal muscle organ development,8/163,98/10799,1.1284217438214172e-4,0.004275464607145591,0.003357219661807872,EGR1/FOS/EGR2/ASB2/IGF2/NR4A1/EOMES/MAFF,8
GO:0001525,angiogenesis,14/163,289/10799,1.1935585697746149e-4,0.00445449322130499,0.0034977981576461096,CCR2/PDGFRB/TNFRSF12A/CXCL8/NRP1/EGR3/HSPB1/ADM/FASLG/NR4A1/TSPAN18/APLN/PDGFA/VAV3,14
GO:1903305,regulation of regulated secretory pathway,7/163,74/10799,1.2083302726413831e-4,0.00445449322130499,0.0034977981576461096,CCR2/ITGAM/CD300A/IL13/KLRC2/ADORA2B/PFN2,7
GO:0009617,response to bacterium,16/163,365/10799,1.2529513828960843e-4,0.004542532313159781,0.00356692902349134,GNLY/FOS/C15orf48/STAP1/CXCL8/ADM/SPON2/FASLG/H2BC8/NR4A1/IL13/FCER1G/CD68/IRF8/AICDA/SRC,16
GO:0002237,response to molecule of bacterial origin,12/163,221/10799,1.2837286715163936e-4,0.004542532313159781,0.00356692902349134,FOS/STAP1/CXCL8/ADM/SPON2/FASLG/NR4A1/IL13/CD68/IRF8/AICDA/SRC,12
GO:0038084,vascular endothelial growth factor signaling pathway,4/163,18/10799,1.297802807204696e-4,0.004542532313159781,0.00356692902349134,PDGFRB/NRP1/HSPB1/PTP4A3,4
GO:0018108,peptidyl-tyrosine phosphorylation,10/163,157/10799,1.2988178901263305e-4,0.004542532313159781,0.00356692902349134,PDGFRB/CD300A/SH3BP5/NRP1/KIT/IGF2/IL13/IL21/PDGFA/SRC,10
GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,10/163,158/10799,1.368814348242218e-4,0.004726741192411101,0.0037115752147540483,PDGFRB/SMPD3/FAM110C/KIT/IGF2/AIM2/CAVIN3/PDGFA/SRC/PIK3AP1,10
GO:0001819,positive regulation of cytokine production,15/163,331/10799,1.4270689342987117e-4,0.004797193175318497,0.0037668961690743713,EGR1/CCR2/KIT/HSPB1/SPON2/HILPDA/IL13/FCER1G/AIM2/IRF8/RSAD2/ARRDC4/ADORA2B/IL21/SRC,15
GO:0002448,mast cell mediated immunity,5/163,34/10799,1.4388508080521843e-4,0.004797193175318497,0.0037668961690743713,CD300A/KIT/SPON2/IL13/ADORA2B,5
GO:0018212,peptidyl-tyrosine modification,10/163,159/10799,1.4419715556309264e-4,0.004797193175318497,0.0037668961690743713,PDGFRB/CD300A/SH3BP5/NRP1/KIT/IGF2/IL13/IL21/PDGFA/SRC,10
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,9/163,130/10799,1.5097013961188848e-4,0.004904043002701978,0.003850797773768531,PDGFRB/FAM110C/KIT/IGF2/AIM2/CAVIN3/PDGFA/SRC/PIK3AP1,9
GO:0051046,regulation of secretion,15/163,333/10799,1.5248336900711224e-4,0.004904043002701978,0.003850797773768531,CCR2/ITGAM/CD300A/SOX4/PTPRN2/SMPD3/STC1/OTOF/GABBR1/IL13/KLRC2/RSAD2/ADORA2B/CPLX1/PFN2,15
GO:0014812,muscle cell migration,6/163,54/10799,1.5301214985727373e-4,0.004904043002701978,0.003850797773768531,PDGFRB/NRP1/PLAU/DOCK5/PDGFA/SRC,6
GO:0070848,response to growth factor,17/163,411/10799,1.5459959612623537e-4,0.004904043002701978,0.003850797773768531,EGR1/FOS/DUSP6/PDGFRB/CDKN2B/SMPD3/CXCL8/NRP1/EGR3/HSPB1/SPRY4/FASLG/NR4A1/SORT1/PTP4A3/APLN/SRC,17
GO:0001667,ameboidal-type cell migration,13/163,261/10799,1.596209924987157e-4,0.005005127213063177,0.003930172047609031,NRP1/EGR3/KIT/HSPB1/STC1/CENPV/NR4A1/CDH2/DOCK5/PDLIM1/PTP4A3/PFN2/SRC,13
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,9/163,134/10799,1.9003098344275198e-4,0.005831611743984201,0.004579151836320362,CD300A/SH3BP5/NRP1/KIT/IGF2/IL13/IL21/PDGFA/SRC,9
GO:0030858,positive regulation of epithelial cell differentiation,5/163,36/10799,1.9025419545989512e-4,0.005831611743984201,0.004579151836320362,ZBED2/CDKN2B/ETV4/IL13/MACROH2A2,5
GO:0008544,epidermis development,10/163,167/10799,2.1552696508141217e-4,0.006532861786023249,0.005129793847259342,ZBED2/TGM5/ETV4/EMP1/MAFF/MACROH2A2/NAB2/JAG2/EDA2R/PDGFA,10
GO:0019221,cytokine-mediated signaling pathway,14/163,308/10799,2.31875866563206e-4,0.0069511798240046805,0.005458269386421333,EGR1/CCR2/STAP1/CCR1/CXCL8/KIT/CCR6/CD70/CCL3L1/ACKR2/FCER1G/AIM2/EDA2R/SRC,14
GO:0043408,regulation of MAPK cascade,16/163,387/10799,2.4457258265050697e-4,0.007227954726335561,0.0056756011221225765,DUSP2/DUSP6/PDGFRB/CCR1/CD300A/NRP1/KIT/IGF2/SPRY4/CCL3L1/BCAR3/CDH2/CAVIN3/EDA2R/PDGFA/SRC,16
GO:0044057,regulation of system process,12/163,237/10799,2.464075474887123e-4,0.007227954726335561,0.0056756011221225765,EGR2/KIT/PDE9A/STC1/ADM/NR4A1/MYL5/MYRF/TNNT3/DOCK5/ADORA2B/APLN,12
GO:0032940,secretion by cell,18/163,471/10799,2.62459892262732e-4,0.007616921128646095,0.005981028899828216,CCR2/CCR1/ITGAM/CD300A/SOX4/PTPRN2/SMPD3/KIT/OTOF/NR4A1/GABBR1/IL13/TSPAN18/KLRC2/RSAD2/ADORA2B/CPLX1/PFN2,18
GO:0048008,platelet-derived growth factor receptor signaling pathway,5/163,39/10799,2.801560007206971e-4,0.00804490073648486,0.006317090985779708,PDGFRB/SMPD3/NRP1/PDGFA/SRC,5
GO:0042119,neutrophil activation,4/163,22/10799,2.959706880974588e-4,0.008410500386769455,0.0066041705074378135,ITGAM/CD300A/CXCL8/FCER1G,4
GO:0090257,regulation of muscle system process,8/163,115/10799,3.416333203598105e-4,0.009607996885995495,0.0075444797279676,KIT/PDE9A/STC1/NR4A1/MYL5/TNNT3/DOCK5/ADORA2B,8
GO:0030335,positive regulation of cell migration,14/163,321/10799,3.5357205857402917e-4,0.009651922328413248,0.0075789712680664305,CCR2/PDGFRB/CCR1/CXCL8/FAM110C/NRP1/KIT/CCR6/HSPB1/DAPK2/PLAU/DOCK5/PDGFA/SRC,14
GO:0036336,dendritic cell migration,4/163,23/10799,3.5409145721680674e-4,0.009651922328413248,0.0075789712680664305,CCR2/CCR1/ASB2/CCR6,4
GO:0045682,regulation of epidermis development,5/163,41/10799,3.5589389988793514e-4,0.009651922328413248,0.0075789712680664305,ZBED2/ETV4/MAFF/MACROH2A2/NAB2,5
GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,7/163,88/10799,3.573475642117808e-4,0.009651922328413248,0.0075789712680664305,PDGFRB/FAM110C/KIT/IGF2/PDGFA/SRC/PIK3AP1,7
GO:0042492,gamma-delta T cell differentiation,3/163,10/10799,3.747737902623542e-4,0.009974767675742471,0.007832478862531229,SOX4/EGR3/JAG2,3
GO:0070663,regulation of leukocyte proliferation,10/163,179/10799,3.7661329567502736e-4,0.009974767675742471,0.007832478862531229,CCR2/CD300A/KIT/IGF2/CD70/IL13/TNFSF9/DLG5/IL21/VAV3,10
GO:0043065,positive regulation of apoptotic process,15/163,363/10799,3.863973770112305e-4,0.010135500427756123,0.007958690913136175,PHLDA1/CDK5R1/MAL/DUSP6/TNFRSF12A/SOX4/PHLDA2/ADM/FASLG/NR4A1/DAPK2/CDKN2A/G0S2/IRF8/SRC,15
GO:0014911,positive regulation of smooth muscle cell migration,4/163,24/10799,4.199441332191394e-4,0.010910548527826783,0.008567281314295227,PDGFRB/NRP1/DOCK5/SRC,4
GO:0001906,cell killing,8/163,119/10799,4.3051870694905134e-4,0.011079764458085018,0.008700154604183908,GNLY/STAP1/ITGAM/KLRD1/GZMB/IL13/KLRC2/IL21,8
GO:1903317,regulation of protein maturation,5/163,43/10799,4.461767495392564e-4,0.011280736540788998,0.008857963752317337,SOX4/PLAUR/PLAU/F12/SRC,5
GO:0043410,positive regulation of MAPK cascade,12/163,253/10799,4.465980741954589e-4,0.011280736540788998,0.008857963752317337,PDGFRB/CCR1/NRP1/KIT/IGF2/CCL3L1/BCAR3/CDH2/CAVIN3/EDA2R/PDGFA/SRC,12
GO:0070665,positive regulation of leukocyte proliferation,8/163,120/10799,4.5544744771227913e-4,0.011398721443661445,0.008950608943452322,CCR2/KIT/IGF2/CD70/IL13/TNFSF9/IL21/VAV3,8
GO:0051249,regulation of lymphocyte activation,15/163,370/10799,4.723826494748753e-4,0.011715089706976907,0.009199030542405465,CCR2/CD300A/SOX4/KLRD1/EGR3/IGF2/CD70/ZNF683/IL13/TNFSF9/KLRC2/DLG5/IL21/VAV3/SRC,15
GO:0009887,animal organ morphogenesis,18/163,496/10799,4.886778276250429e-4,0.012010028051901956,0.009430624743641178,ASB2/SOX4/PHLDA2/SMPD3/NRP1/IGF2/STC1/ADM/FASLG/BCAR3/CDH2/SLIT1/DLG5/NAB2/JAG2/PDGFA/WNT9A/SRC,18
GO:2000147,positive regulation of cell motility,14/163,332/10799,4.958670046844877e-4,0.012077903471243594,0.009483922505008763,CCR2/PDGFRB/CCR1/CXCL8/FAM110C/NRP1/KIT/CCR6/HSPB1/DAPK2/PLAU/DOCK5/PDGFA/SRC,14
GO:0010755,regulation of plasminogen activation,3/163,11/10799,5.09613470254041e-4,0.012194960937307228,0.009575839445678426,PLAUR/PLAU/F12,3
GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,3/163,11/10799,5.09613470254041e-4,0.012194960937307228,0.009575839445678426,PDGFRB/PDGFA/SRC,3
GO:0006897,endocytosis,17/163,457/10799,5.330562952751203e-4,0.01264502237835242,0.009929240831898122,CCR2/STAP1/ITGAM/CD300A/CXCL8/CD93/SCARF1/ADM/SPON2/ACKR2/FCER1G/SORT1/MLC1/IRF8/APLN/VAV3/SRC,17
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,5/163,45/10799,5.527238356931416e-4,0.012998539860093881,0.010206833081992224,STAP1/ITGAM/KLRD1/KLRC2/IL21,5
GO:0043068,positive regulation of programmed cell death,15/163,377/10799,5.742911339648426e-4,0.013011234570124345,0.010216801339019541,PHLDA1/CDK5R1/MAL/DUSP6/TNFRSF12A/SOX4/PHLDA2/ADM/FASLG/NR4A1/DAPK2/CDKN2A/G0S2/IRF8/SRC,15
GO:0040017,positive regulation of locomotion,14/163,337/10799,5.751887466868934e-4,0.013011234570124345,0.010216801339019541,CCR2/PDGFRB/CCR1/CXCL8/FAM110C/NRP1/KIT/CCR6/HSPB1/DAPK2/PLAU/DOCK5/PDGFA/SRC,14
GO:0030193,regulation of blood coagulation,4/163,26/10799,5.771112107716443e-4,0.013011234570124345,0.010216801339019541,PLAUR/PLAU/F12/PDGFA,4
GO:1900046,regulation of hemostasis,4/163,26/10799,5.771112107716443e-4,0.013011234570124345,0.010216801339019541,PLAUR/PLAU/F12/PDGFA,4
GO:1903307,positive regulation of regulated secretory pathway,4/163,26/10799,5.771112107716443e-4,0.013011234570124345,0.010216801339019541,ITGAM/IL13/KLRC2/ADORA2B,4
GO:0070374,positive regulation of ERK1 and ERK2 cascade,7/163,96/10799,6.067320069300739e-4,0.013566925532010178,0.010653146109600522,PDGFRB/CCR1/NRP1/CCL3L1/CAVIN3/PDGFA/SRC,7
GO:0001938,positive regulation of endothelial cell proliferation,5/163,46/10799,6.126536553424936e-4,0.013587960746132704,0.010669663574000638,NRP1/EGR3/IGF2/NR4A1/APLN,5
GO:0010631,epithelial cell migration,10/163,191/10799,6.276911966132663e-4,0.013698732674887925,0.010756644927225239,NRP1/EGR3/KIT/HSPB1/STC1/NR4A1/DOCK5/PTP4A3/PFN2/SRC,10
GO:0090132,epithelium migration,10/163,191/10799,6.276911966132663e-4,0.013698732674887925,0.010756644927225239,NRP1/EGR3/KIT/HSPB1/STC1/NR4A1/DOCK5/PTP4A3/PFN2/SRC,10
GO:0000165,MAPK cascade,17/163,464/10799,6.329145166353449e-4,0.013703101598263658,0.010760075533441328,DUSP2/DUSP6/PDGFRB/CCR1/CD300A/NRP1/KIT/IGF2/SPRY4/CCL3L1/BCAR3/CDH2/CAVIN3/EDA2R/PDGFA/MAP3K6/SRC,17
GO:0090130,tissue migration,10/163,192/10799,6.537182498789272e-4,0.01404207390291113,0.011026246485732425,NRP1/EGR3/KIT/HSPB1/STC1/NR4A1/DOCK5/PTP4A3/PFN2/SRC,10
GO:0072677,eosinophil migration,3/163,12/10799,6.719732662049786e-4,0.014321430235993606,0.011245605236242857,CD300A/DAPK2/CCL3L1,3
GO:0007517,muscle organ development,10/163,194/10799,7.084537875528358e-4,0.01498187544530338,0.011764206100938564,EGR1/FOS/EGR2/ASB2/EGR3/IGF2/ETV1/NR4A1/EOMES/MAFF,10
GO:0002285,lymphocyte activation involved in immune response,9/163,161/10799,7.354675077610458e-4,0.0154192125516355,0.01210761596796506,CCR6/ZNF683/EOMES/FCER1G/KLRC2/IRF8/AICDA/IL21/RORC,9
GO:0031341,regulation of cell killing,6/163,72/10799,7.404387259033177e-4,0.0154192125516355,0.01210761596796506,STAP1/ITGAM/KLRD1/IL13/KLRC2/IL21,6
GO:0031343,positive regulation of cell killing,5/163,48/10799,7.469769207260565e-4,0.015437523028338502,0.01212199388897548,STAP1/ITGAM/KLRD1/KLRC2/IL21,5
GO:0050670,regulation of lymphocyte proliferation,9/163,162/10799,7.688387836204419e-4,0.015601227720771733,0.012250539593984594,CCR2/CD300A/IGF2/CD70/IL13/TNFSF9/DLG5/IL21/VAV3,9
GO:0006968,cellular defense response,4/163,28/10799,7.720548908739677e-4,0.015601227720771733,0.012250539593984594,CCR2/GNLY/CCR6/KLRC2,4
GO:0061045,negative regulation of wound healing,4/163,28/10799,7.720548908739677e-4,0.015601227720771733,0.012250539593984594,PLAUR/PLAU/F12/PDGFA,4
GO:0030219,megakaryocyte differentiation,5/163,49/10799,8.218424007992095e-4,0.016485191686619438,0.012944653913516962,CDKN2B/KIT/H4C6/H4C4/GP5,5
GO:1903530,regulation of secretion by cell,13/163,311/10799,8.550778082639072e-4,0.0168044631797575,0.013195355213307036,CCR2/ITGAM/CD300A/SOX4/SMPD3/OTOF/GABBR1/IL13/KLRC2/RSAD2/ADORA2B/CPLX1/PFN2,13
GO:0002688,regulation of leukocyte chemotaxis,6/163,74/10799,8.5647141615094e-4,0.0168044631797575,0.013195355213307036,CCR2/STAP1/CCR1/CXCL8/CCR6/DAPK2,6
GO:0031639,plasminogen activation,3/163,13/10799,8.639151464204894e-4,0.0168044631797575,0.013195355213307036,PLAUR/PLAU/F12,3
GO:0002705,positive regulation of leukocyte mediated immunity,7/163,102/10799,8.718164240849569e-4,0.0168044631797575,0.013195355213307036,STAP1/ITGAM/KLRD1/KIT/KLRC2/RSAD2/IL21,7
GO:0032944,regulation of mononuclear cell proliferation,9/163,165/10799,8.764392177569833e-4,0.0168044631797575,0.013195355213307036,CCR2/CD300A/IGF2/CD70/IL13/TNFSF9/DLG5/IL21/VAV3,9
GO:0071363,cellular response to growth factor stimulus,15/163,393/10799,8.799046429887231e-4,0.0168044631797575,0.013195355213307036,EGR1/FOS/PDGFRB/CDKN2B/SMPD3/CXCL8/NRP1/EGR3/HSPB1/SPRY4/NR4A1/SORT1/PTP4A3/APLN/SRC,15
GO:0050818,regulation of coagulation,4/163,29/10799,8.851414203858939e-4,0.0168044631797575,0.013195355213307036,PLAUR/PLAU/F12/PDGFA,4
GO:0042060,wound healing,11/163,236/10799,8.917750020724446e-4,0.0168044631797575,0.013195355213307036,TNFRSF12A/PLAUR/HSPB1/F5/FCER1G/PLAU/F12/PDGFA/GP5/VAV3/SRC,11
GO:0010001,glial cell differentiation,8/163,133/10799,9.004581391502287e-4,0.0168044631797575,0.013195355213307036,MAL/EGR2/SOX4/GPR157/EOMES/CDH2/MYRF/NAB2,8
GO:0044344,cellular response to fibroblast growth factor stimulus,5/163,50/10799,9.021644330096644e-4,0.0168044631797575,0.013195355213307036,CXCL8/EGR3/SPRY4/NR4A1/APLN,5
GO:0045859,regulation of protein kinase activity,14/163,353/10799,9.055190936306276e-4,0.0168044631797575,0.013195355213307036,CDK5R1/EGR1/PDGFRB/CD300A/CDKN2B/SH3BP5/KIT/HSPB1/SPRY4/CDKN2A/DBNDD2/NAB2/PDGFA/SRC,14
GO:0045921,positive regulation of exocytosis,5/163,51/10799,9.881876670355715e-4,0.01821470240319621,0.01430271623340959,ITGAM/SMPD3/IL13/KLRC2/ADORA2B,5
GO:0097530,granulocyte migration,6/163,77/10799,0.001056238389530742,0.019338378031140028,0.015185059150088732,CD300A/CXCL8/DAPK2/CCL3L1/FCER1G/VAV3,6
GO:0045618,positive regulation of keratinocyte differentiation,3/163,14/10799,0.0010873905897494682,0.019388245286513395,0.015224216375233352,ZBED2/ETV4/MACROH2A2,3
GO:0061437,renal system vasculature development,3/163,14/10799,0.0010873905897494682,0.019388245286513395,0.015224216375233352,EGR1/PDGFRB/NRP1,3
GO:0061440,kidney vasculature development,3/163,14/10799,0.0010873905897494682,0.019388245286513395,0.015224216375233352,EGR1/PDGFRB/NRP1,3
GO:1903975,regulation of glial cell migration,3/163,14/10799,0.0010873905897494682,0.019388245286513395,0.015224216375233352,CCR2/STAP1/BMERB1,3
GO:0030168,platelet activation,6/163,78/10799,0.0011302026032173533,0.02002073182842169,0.015720863277835367,HSPB1/FCER1G/PDGFA/GP5/VAV3/SRC,6
GO:0002685,regulation of leukocyte migration,8/163,138/10799,0.0011444537030908153,0.020142385174398352,0.015816389037621795,CCR2/STAP1/CCR1/CD300A/SMPD3/CXCL8/CCR6/DAPK2,8
GO:0050671,positive regulation of lymphocyte proliferation,7/163,107/10799,0.0011561932906859133,0.020218559596097252,0.01587620341798808,CCR2/IGF2/CD70/IL13/TNFSF9/IL21/VAV3,7
GO:0002449,lymphocyte mediated immunity,10/163,207/10799,0.0011640620367176493,0.020226504688953807,0.015882442136911944,CCR2/KLRD1/GZMB/CCR6/CD70/FCER1G/KLRC2/RSAD2/AICDA/IL21,10
GO:0030593,neutrophil chemotaxis,5/163,53/10799,0.0011783315000093587,0.02034486286092108,0.015975380429840407,CXCL8/DAPK2/CCL3L1/FCER1G/VAV3,5
GO:1903034,regulation of response to wounding,6/163,79/10799,0.0012080755275178303,0.02072723295011724,0.016275628589862857,TNFRSF12A/PLAUR/SCARF1/PLAU/F12/PDGFA,6
GO:0071774,response to fibroblast growth factor,5/163,54/10799,0.0012829559234942662,0.02187439849557724,0.017176416475729157,CXCL8/EGR3/SPRY4/NR4A1/APLN,5
GO:0043303,mast cell degranulation,4/163,32/10799,0.0012938505546896024,0.021923132380082207,0.017214683744971173,CD300A/KIT/IL13/ADORA2B,4
GO:0032946,positive regulation of mononuclear cell proliferation,7/163,110/10799,0.0013588849614524074,0.02288295169655659,0.01796836190094639,CCR2/IGF2/CD70/IL13/TNFSF9/IL21/VAV3,7
GO:0002279,mast cell activation involved in immune response,4/163,33/10799,0.0014551777109225448,0.02435413984905952,0.01912358179998307,CD300A/KIT/IL13/ADORA2B,4
GO:0001934,positive regulation of protein phosphorylation,14/163,372/10799,0.00149352379397034,0.02484349335336029,0.019507836461679348,EGR1/PDGFRB/CD300A/PLAUR/NRP1/KIT/IGF2/IL13/BCAR3/NAB2/IL21/PDGFA/PFN2/SRC,14
GO:0002065,columnar/cuboidal epithelial cell differentiation,5/163,56/10799,0.0015125879523244492,0.024857469481572875,0.019518810925683285,SOX4/IL13/CDH2/DLG5/SRC,5
GO:0002690,positive regulation of leukocyte chemotaxis,5/163,56/10799,0.0015125879523244492,0.024857469481572875,0.019518810925683285,CCR2/CCR1/CXCL8/CCR6/DAPK2,5
GO:0002223,stimulatory C-type lectin receptor signaling pathway,3/163,16/10799,0.0016362162120148402,0.026411821457849014,0.020739333487699782,KLRD1/KLRC2/SRC,3
GO:1990840,response to lectin,3/163,16/10799,0.0016362162120148402,0.026411821457849014,0.020739333487699782,KLRD1/KLRC2/SRC,3
GO:1990858,cellular response to lectin,3/163,16/10799,0.0016362162120148402,0.026411821457849014,0.020739333487699782,KLRD1/KLRC2/SRC,3
GO:0051251,positive regulation of lymphocyte activation,11/163,255/10799,0.0016652663621972515,0.02672262727102413,0.020983387288367843,CCR2/SOX4/EGR3/IGF2/CD70/IL13/TNFSF9/KLRC2/IL21/VAV3/SRC,11
GO:0061041,regulation of wound healing,5/163,58/10799,0.001771126769383801,0.02825516857823982,0.022186783476122098,TNFRSF12A/PLAUR/PLAU/F12/PDGFA,5
GO:0001656,metanephros development,4/163,35/10799,0.0018189433543210288,0.028682528731721193,0.022522359148422842,EGR1/PDGFRB/DLG5/PDGFA,4
GO:0019730,antimicrobial humoral response,4/163,35/10799,0.0018189433543210288,0.028682528731721193,0.022522359148422842,GNLY/CXCL8/SPON2/H2BC8,4
GO:0060491,regulation of cell projection assembly,8/163,149/10799,0.0018677169897864713,0.029216405997215863,0.0229415751675931,FSCN1/STAP1/FAM110C/NRP1/KIT/AGRN/PFN2/SRC,8
GO:0030856,regulation of epithelial cell differentiation,6/163,86/10799,0.0018742195929299032,0.029216405997215863,0.0229415751675931,ZBED2/CDKN2B/ETV4/IL13/MAFF/MACROH2A2,6
GO:0002407,dendritic cell chemotaxis,3/163,17/10799,0.0019649474681449116,0.029779870517218438,0.023384023963011084,CCR2/CCR1/CCR6,3
GO:0008045,motor neuron axon guidance,3/163,17/10799,0.0019649474681449116,0.029779870517218438,0.023384023963011084,EGR2/NRP1/SLIT1,3
GO:0035272,exocrine system development,3/163,17/10799,0.0019649474681449116,0.029779870517218438,0.023384023963011084,NRP1/IGF2/PDGFA,3
GO:0060563,neuroepithelial cell differentiation,3/163,17/10799,0.0019649474681449116,0.029779870517218438,0.023384023963011084,SOX4/CDH2/DLG5,3
GO:1903319,positive regulation of protein maturation,3/163,17/10799,0.0019649474681449116,0.029779870517218438,0.023384023963011084,SOX4/F12/SRC,3
GO:0045604,regulation of epidermal cell differentiation,4/163,36/10799,0.002022529499178666,0.030483207037344758,0.0239363043374736,ZBED2/ETV4/MAFF/MACROH2A2,4
GO:0001936,regulation of endothelial cell proliferation,5/163,60/10799,0.002060672104419742,0.03088743681789591,0.024253717365495517,NRP1/EGR3/IGF2/NR4A1/APLN,5
GO:0070372,regulation of ERK1 and ERK2 cascade,8/163,153/10799,0.0022059141360209382,0.032873023600248366,0.025812858090178054,DUSP6/PDGFRB/CCR1/NRP1/CCL3L1/CAVIN3/PDGFA/SRC,8
GO:0071621,granulocyte chemotaxis,5/163,61/10799,0.0022177346297178233,0.032873023600248366,0.025812858090178054,CXCL8/DAPK2/CCL3L1/FCER1G/VAV3,5
GO:0006959,humoral immune response,6/163,89/10799,0.002232399568880897,0.032873023600248366,0.025812858090178054,CCR2/GNLY/CXCL8/CCR6/SPON2/H2BC8,6
GO:0008347,glial cell migration,4/163,37/10799,0.0022413425181987525,0.032873023600248366,0.025812858090178054,CDK5R1/CCR2/STAP1/BMERB1,4
GO:0002440,production of molecular mediator of immune response,8/163,154/10799,0.0022975544983122576,0.03351726562243764,0.02631873573918066,CCR2/KIT/CCR6/SPON2/IL13/RSAD2/AICDA/IL21,8
GO:0045606,positive regulation of epidermal cell differentiation,3/163,18/10799,0.002331980905629798,0.03383853143913877,0.02657100304007077,ZBED2/ETV4/MACROH2A2,3
GO:1903035,negative regulation of response to wounding,4/163,38/10799,0.002475944533745804,0.0357374427939606,0.02806208368795718,PLAUR/PLAU/F12/PDGFA,4
GO:0006334,nucleosome assembly,6/163,91/10799,0.002498362092682943,0.03581260453725434,0.02812110288366746,H4C6/H2BC8/H1-0/H3C1/H4C4/MACROH2A2,6
GO:0001666,response to hypoxia,9/163,192/10799,0.0025074074291112827,0.03581260453725434,0.02812110288366746,EGR1/FOS/SOX4/STC1/ADM/HILPDA/PLAU/PDLIM1/SRC,9
GO:0043549,regulation of kinase activity,14/163,394/10799,0.002543635499903928,0.036140821061134976,0.028378828082809723,CDK5R1/EGR1/PDGFRB/CD300A/CDKN2B/SH3BP5/KIT/HSPB1/SPRY4/CDKN2A/DBNDD2/NAB2/PDGFA/SRC,14
GO:0001909,leukocyte mediated cytotoxicity,6/163,92/10799,0.002639949893769068,0.03731493943109854,0.0293007801135536,STAP1/ITGAM/KLRD1/GZMB/KLRC2/IL21,6
GO:0070661,leukocyte proliferation,10/163,232/10799,0.0027060165479927457,0.03796054371834999,0.029807727452863957,CCR2/CD300A/KIT/IGF2/CD70/IL13/TNFSF9/DLG5/IL21/VAV3,10
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,3/163,19/10799,0.002738765518093193,0.03796054371834999,0.029807727452863957,PLAUR/FASLG/BCAR3,3
GO:0001910,regulation of leukocyte mediated cytotoxicity,5/163,64/10799,0.0027412855984292332,0.03796054371834999,0.029807727452863957,STAP1/ITGAM/KLRD1/KLRC2/IL21,5
GO:0042100,B cell proliferation,5/163,64/10799,0.0027412855984292332,0.03796054371834999,0.029807727452863957,CD300A/CD70/IL13/IL21/VAV3,5
GO:0030855,epithelial cell differentiation,13/163,355/10799,0.002786355048351407,0.038212281255672303,0.030005399118418413,ZBED2/CDKN2B/SOX4/ETV4/NRP1/STC1/IL13/CDH2/MAFF/DLG5/MACROH2A2/JAG2/SRC,13
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,6/163,93/10799,0.0027874794610992628,0.038212281255672303,0.030005399118418413,NRP1/KIT/IGF2/IL13/IL21/SRC,6
GO:0019932,second-messenger-mediated signaling,8/163,160/10799,0.00291200751123183,0.03942475179392386,0.030957466391663472,CCR2/PDGFRB/CCR1/CXCL8/CCR6/ADM/ACKR2/ADORA2B,8
GO:0042327,positive regulation of phosphorylation,14/163,400/10799,0.0029176624861034428,0.03942475179392386,0.030957466391663472,EGR1/PDGFRB/CD300A/PLAUR/NRP1/KIT/IGF2/IL13/BCAR3/NAB2/IL21/PDGFA/PFN2/SRC,14
GO:0051338,regulation of transferase activity,16/163,489/10799,0.0029192814744767666,0.03942475179392386,0.030957466391663472,CDK5R1/EGR1/PDGFRB/CD300A/CDKN2B/SH3BP5/KIT/HSPB1/IGF2/SPRY4/CDKN2A/DBNDD2/NAB2/ARRDC4/PDGFA/SRC,16
GO:0050804,modulation of chemical synaptic transmission,10/163,235/10799,0.002968522001364772,0.03989225625479359,0.03132456454642111,CCR2/EGR2/KIT/PDE9A/OTOF/GABBR1/CDH2/ADORA2B/CPLX1/PFN2,10
GO:0038093,Fc receptor signaling pathway,4/163,40/10799,0.0029947340721472836,0.040047228180479365,0.03144625302796555,KIT/FCER1G/VAV3/SRC,4
GO:0099177,regulation of trans-synaptic signaling,10/163,236/10799,0.003060413461510449,0.04072589230731953,0.03197915991873563,CCR2/EGR2/KIT/PDE9A/OTOF/GABBR1/CDH2/ADORA2B/CPLX1/PFN2,10
GO:0097191,extrinsic apoptotic signaling pathway,8/163,162/10799,0.00314305896556909,0.04159428871584762,0.03266105013765624,MAL/TNFRSF12A/NRP1/CD70/FASLG/SORT1/G0S2/SRC,8
GO:0048483,autonomic nervous system development,3/163,20/10799,0.0031866592161334866,0.04159428871584762,0.03266105013765624,EGR2/SOX4/NRP1,3
GO:0055094,response to lipoprotein particle,3/163,20/10799,0.0031866592161334866,0.04159428871584762,0.03266105013765624,SMPD3/FCER1G/CD68,3
GO:0071404,cellular response to low-density lipoprotein particle stimulus,3/163,20/10799,0.0031866592161334866,0.04159428871584762,0.03266105013765624,SMPD3/FCER1G/CD68,3
GO:0007422,peripheral nervous system development,4/163,41/10799,0.00328001409076991,0.042206973771793936,0.033142148335237175,EGR2/EGR3/ETV1/NAB2,4
GO:0045576,mast cell activation,4/163,41/10799,0.00328001409076991,0.042206973771793936,0.033142148335237175,CD300A/KIT/IL13/ADORA2B,4
GO:0070613,regulation of protein processing,4/163,41/10799,0.00328001409076991,0.042206973771793936,0.033142148335237175,PLAUR/PLAU/F12/SRC,4
GO:1990266,neutrophil migration,5/163,67/10799,0.0033490155819168275,0.04272075805933036,0.03354558676135873,CXCL8/DAPK2/CCL3L1/FCER1G/VAV3,5
GO:0050863,regulation of T cell activation,11/163,279/10799,0.003351261812572103,0.04272075805933036,0.03354558676135873,CCR2/CD300A/SOX4/EGR3/IGF2/CD70/ZNF683/TNFSF9/DLG5/IL21/SRC,11
GO:0071900,regulation of protein serine/threonine kinase activity,9/163,201/10799,0.0034061602752900586,0.04309291217181757,0.033837813038141984,CDK5R1/PDGFRB/CD300A/CDKN2B/KIT/SPRY4/CDKN2A/PDGFA/SRC,9
GO:0045785,positive regulation of cell adhesion,12/163,321/10799,0.0034120487643374614,0.04309291217181757,0.033837813038141984,CCR2/SOX4/PLAUR/NRP1/EGR3/IGF2/CD70/TNFSF9/DOCK5/IL21/VAV3/SRC,12
GO:0071396,cellular response to lipid,13/163,365/10799,0.0035340596319030117,0.04442817822963786,0.03488630293923177,FOS/STAP1/CXCL8/RXRA/STC1/SPON2/MLC1/CD68/IRF8/AICDA/WNT9A/RORC/SRC,13
GO:0050808,synapse organization,10/163,241/10799,0.003554553740884644,0.04448083763822619,0.034927652644617335,CDK5R1/ITGAM/NPTX1/NRP1/CDH2/SORT1/SLIT1/DLG5/AGRN/PFN2,10
GO:0045684,positive regulation of epidermis development,3/163,21/10799,0.003676931781047757,0.04538764660044471,0.03563970552242051,ZBED2/ETV4/MACROH2A2,3
GO:0046629,gamma-delta T cell activation,3/163,21/10799,0.003676931781047757,0.04538764660044471,0.03563970552242051,SOX4/EGR3/JAG2,3
GO:1901186,positive regulation of ERBB signaling pathway,3/163,21/10799,0.003676931781047757,0.04538764660044471,0.03563970552242051,PLAUR/FASLG/BCAR3,3
GO:0036293,response to decreased oxygen levels,9/163,206/10799,0.004005186539932669,0.04921688685106451,0.038646536788823994,EGR1/FOS/SOX4/STC1/ADM/HILPDA/PLAU/PDLIM1/SRC,9
GO:1902414,protein localization to cell junction,5/163,70/10799,0.004048174925342926,0.04951826823611521,0.038883190253316276,NPTX1/HSPB1/TAMALIN/DLG5/CPLX1,5
GO:0070371,ERK1 and ERK2 cascade,8/163,169/10799,0.0040660161601502225,0.04951826823611521,0.038883190253316276,DUSP6/PDGFRB/CCR1/NRP1/CCL3L1/CAVIN3/PDGFA/SRC,8
